• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORP. TERUMO PERFUSION SYSTEM 8000; 8K (PUMP, ROLLER TYPE)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORP. TERUMO PERFUSION SYSTEM 8000; 8K (PUMP, ROLLER TYPE) Back to Search Results
Model Number 16402
Device Problem Pumping Problem (3016)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/11/2014
Event Type  No Answer Provided  
Event Description
It was reported that during use of the device for a cardiopulmonary bypass (cpb) procedure, the occlusion on the arterial roller pump was drifting.The customer hypoperfused the pt.The device was not changed out.After the case, the roller pump was moved to a vent pump.The surgical procedure was completed successfully.There were no delays, no blood loss, or no adverse consequences to the pt.Per the clinical review on 06/12/2014: the perfusionist (ccp) had some difficulty in setting the occlusion of the arterial pump during the set-up and priming stages of the cpb circuit, prior to cpb.The ccp experienced a few pump jams during priming and they felt the occlusion was "on the tighter" side.During cpb, the pt became acidotic (low arterial blood ph) and was hypotensive (low blood pressure).Sodium bicarbonate was administered, during cpb, to treat the acidosis.Roller occlusions were not adjusted during cpb.The surgical procedure was completed successfully without delay and without associated blood loss.The pt was weaned from cpb, without issue, and there was no harm observed or reported.After cpb, had been completed, the ccp checked the occlusion of the arterial roller pump and it was less (looser) than their normal practice.With the acidosis and hypotension during cpb, the clinical team believes that loose occlusion may have had an impact on the adequacy of blood flow.At this time, it is not clear if the looser than normal occlusion was due to a functional failure of the pump or due to use error in setting occlusion.
 
Manufacturer Narrative
Eval is in progress, but not yet concluded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TERUMO PERFUSION SYSTEM 8000
Type of Device
8K (PUMP, ROLLER TYPE)
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORP.
ann arbor MI 48103
Manufacturer Contact
jan winder
6200 jackson rd.
ann arbor, MI 48103
7346634145
MDR Report Key3947778
MDR Text Key4641825
Report Number1828100-2014-00572
Device Sequence Number1
Product Code DWB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K953901
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 06/12/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number16402
Device Catalogue Number16402
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer06/20/2014
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/12/2014
Initial Date FDA Received07/02/2014
Was Device Evaluated by Manufacturer? No
Date Device Manufactured04/01/2012
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-